The so-called liquid facelift has once again been featured by a national media outlet. Harper’s Baazar recently posted an excellent article that outlines the pros and cons of all the latest wrinkle fillers. The Best Beauty section of the September issue includes before and after pictures and a discussion of professional techniques for administering injectables.
The idea of a liquid facelift isn’t exactly a “touch up” here and there, but a relatively extensive series of injections intended to achieve results similar to a surgical facelift, yet the results are “typically more subtle than surgery.” According to the authors, you can expect to pay at least $3,000 for a full liquid facelift. A Florida dermatologist by the name of Dr. Fredric Brandt explains, “I resuspend the face with Botox, lifting up the brows, neck, jawline, and tip of the nose and then fill in and replace volume around the eyes and cheeks.” Some of the products and procedures discussed in the aforementioned article include Juvederm, Restylane, Perlane, Botox, Sculptra, and fat transfer.
The liquid facelift has also been featured on The Doctors (NBC), Rachel Ray Show, New Beauty Magazine, Dr. 90210, FOX News, Cosmetic Surgery Times, and more exposure is said to be in the works.
For more information, you might want to view www.liquidfacelift.com/ or contact us at the office of Dr. Mandell-Brown.
Although the economic news this week is looking optimistic, the job market is still a rough environment to navigate. We’ve had more than one patient comment about it and share suspicions about age, or appearance, negatively affecting job prospects. My neighbor told me last week that her job interviews hadn’t gone as well as she’d hoped and her explanation was, “if it isn’t my qualifications, it must be the crow’s feet.”
Yesterday brought an exciting announcement from pharmaceutical company sanofi-aventis; Sculptra has been FDA cleared for physicians to use in additional facial cosmetic procedures. Even though off-label cosmetic use of Sculptra is common and has been happening for years, original approval of the filler was for treating lipoatrophy, i.e. facial fat loss, in AIDS patients. Professionals in the industry are excited to get official clearance for this long-lasting dermal filler.
Many of us in the industry probably remember when collagen first received FDA approval over 20 years ago. People considering it at the time were hopeful about looking better, but scared about allergic reactions, painful injections, and swelling. In 2009, we have a wider variety of fillers to choose from that are safe and effective.
Trained surgeons know that healthy patients have more consistently successful surgery outcomes. Those who engage in unhealthy habits (smoking for example) face a greater risk of complications. That’s why surgeons often decline to operate on such patients.
Researchers associated with the American Society for Aesthetic Plastic Surgery (ASAPS) sent questionnaires last March to 687 patients who had received Botox and/or dermal filler treatment. The findings offer some insight about the treatments and the patients who choose them.
